Company Encyclopedia
View More
name
WERIDE-W
00800.HK
WeRide Inc., an investment holding company, provides autonomous driving products and solutions for mobility, logistics, and sanitation industries in the People’s Republic of China. Its product categories include robotaxis, robobus, robovan, and robosweeper. The company also offers advanced driver-assistance system solutions; and WeRide Go app, an online ride-hailing platform. WeRide Inc.
481.36 B
00800.HKMarket value -Rank by Market Cap -/-

Financial Score

07/11/2025 Update
C
Automotive Parts and EquipmentIndustry
Industry Ranking15/29
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-173.78%E
    • Profit Margin-591.21%E
    • Gross Margin28.07%C
  • Growth ScoreB
    • Revenue YoY11.32%B
    • Net Profit YoY-15.31%D
    • Total Assets YoY38.72%A
    • Net Assets YoY36.80%A
  • Cash ScoreC
    • Cash Flow Margin-16.91%D
    • OCF YoY11.32%B
  • Operating ScoreE
    • Turnover0.07E
  • Debt ScoreA
    • Gearing Ratio9.55%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    The Nasdaq Golden Dragon China Index preliminarily closed down 1%, with a cumulative decline of about 2.6% this week. Among popular Chinese concept stocks, WeRide fell over 7%, XPeng fell about 6%, PONY-W fell 5.3%, and Nio fell about 4%; H World rose 2%, Vipshop rose 2.3%, Canadian Solar rose 6.2%, and Daqo New Energy rose 9.7%. In ETFs, CQQQ and KWEB fell by up to 1.8%

    Wallstreetcn·
    US
    HTHT
    +2.04%
    HK
    01179
    -1.57%
    US
    DQ
    +9.48%
    Wallstreetcn·
    US
    HTHT
    +2.04%
    HK
    01179
    -1.57%
    US
    DQ
    +9.48%

    The Hang Seng Index closed down 0.92%, and the Hang Seng Tech Index fell 1.8%

    WERIDE-W fell about 13%, PONY-W fell about 12%, POP MART fell about 6%, Kuaishou fell about 6%, Nio fell about 5%

    Wallstreetcn·
    HK
    00800
    -13.44%
    HK
    02026
    -11.26%
    HK
    09992
    -5.88%
    Wallstreetcn·
    HK
    00800
    -13.44%
    HK
    02026
    -11.26%
    HK
    09992
    -5.88%

    "New Stocks" WeRide-W half-day closing at 23.4 yuan, down 13.7% from the listing price

    WeRide-W listed on its first day, opening at 24.98 yuan, down 7.8% from the listing price of 27.1 yuan. The highest/lowest prices were 24.98/23 yuan, closing at 23.4 yuan, down 13.7% from the listing price of 27.1 yuan. The half-day trading volume was 10.4704 million shares, involving 250 million yuan

    AASTOCKS·
    HK
    00800
    -13.44%
    US
    WRD
    -6.66%
    AASTOCKS·
    HK
    00800
    -13.44%
    US
    WRD
    -6.66%

    On the first day of trading, VIGONVITA opened with a rise of over 185%, as the company is committed to drug development in the fields of neuropsychiatry and reproductive health

    On November 6th (Thursday), four new stocks were listed today, among which VIGONVITA (02630) opened with a rise of over 185%, trading at HKD 95, making it the only new stock among the four to rise in the dark market. Excluding fees, a single lot of 200 shares would yield a profit of HKD 12,326. The IPO results for VIGONVITA show that the public offering was oversubscribed by 6,237.42 times, with a subscription rate of 1.68% for one lot, and the international offering was oversubscribed by 15.87 times. VIGONVITA was established in 2013 and is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing small molecule drugs in its strategic therapeutic areas (namely, neuropsychiatry and reproductive health). The company has acquired and developed two core products, LV232 and TPN171. LV232 is a dual-target 5-hydroxytryptamine transporter/5-hydroxytryptamine 3 (5-HTT/5-HT3) receptor modulator for the treatment of major depressive disorder. TPN171 is a type 5 phosphodiesterase (PDE5) inhibitor for the treatment of erectile dysfunction (ED). The company also has four candidate drugs in clinical stages and three candidate drugs in preclinical stages. In addition to its innovative pipeline, the company is also advancing its generic drug pipeline, aiming to generate visible, recurring revenue streams and cash flow as a strategic supplement to its business, thereby enhancing overall resilience

    LB Select·
    HK
    02630
    -19.39%
    HK
    02026
    -11.26%
    HK
    00800
    -13.44%
    LB Select·
    HK
    02630
    -19.39%
    HK
    02026
    -11.26%
    HK
    00800
    -13.44%

    The first day opening price of WeRide-W is 24.98 yuan, down 7.8% from the listing price

    WERIDE-W closed at HKD 23.3 in the dark market yesterday, 14.0% lower than the listing price. Today is the first day of listing, opening at HKD 24.98, which is 7.8% lower than the listing price of HKD 27.1, with a trading volume of 6.0797 million shares during the opening session

    AASTOCKS·
    US
    WRD
    -6.66%
    HK
    00800
    -13.44%
    AASTOCKS·
    US
    WRD
    -6.66%
    HK
    00800
    -13.44%
    Posts
    View More

    $Uber Tech(UBER.US) +1.0% today on news it will partner with $Lucid(LCID.US) and Nuro to launch a fully autonomous ride hailing service with an initial 100 vehicles in SFO by the end of next year. W...

    .....................

    $Pony AI(PONY.US) +9.4% and $WeRide(WRD.US) +7.0% on

    news that $Uber Tech(UBER.US) was planning to invest in the autonomous manufacturers’ latest equity raises. While many here have disagreed with our............
    • 0